No Data
No Data
Berry Genomics (000710.SZ): Currently connected to various open-source models such as Deepseek, Qianwen, llama, Zhipu AI, BiomedGPT, and LucaOne.
On February 12, Longhu reported that Berry Genomics (000710.SZ) recently expressed during an investor relations event that the company has now accessed multiple open-source models such as Deepseek, Qianwen, Llama, Asia Vets AI, BiomedGPT, and LucaOne. Through the application of large models, the company aims to enhance operational efficiency, reduce operational costs, and provide higher quality services to its clinical clients. To date, Berry has reached a global strategy with several large medical institutions and plans to develop AI Big Data construction based on molecular diagnostics and genetic disease consulting, gradually expanding into other fields, expected within the year.
Berry GenomicsLtd (SZSE:000710) Shareholder Returns Have Been Decent, Earning 83% in 1 Year
Berry Genomics: 2024 Annual Results Forecast
Berry Genomics (000710.SZ): A forecasted loss of 0.17 billion to -0.25 billion yuan for the year 2024.
Gelonghui, January 22 - Berry Genomics (000710.SZ) announced its performance forecast for 2024. The net income attributable to shareholders of the listed company is expected to be a loss of 0.17 billion yuan to -0.25 billion yuan, a reduction in losses of 41.48% to 60.21% compared to the same period last year; the net income after deducting non-recurring gains and losses is expected to be a loss of 0.168 billion yuan to -0.248 billion yuan, a reduction in losses of 40.51% to 59.70% year-on-year; the basic EPS is expected to be a loss of 0.48 yuan/share to 0.71 yuan/share. During the reporting period, competition in the genetic testing market remains quite fierce, and facing a complex market environment, the company focuses on.
Little Excitement Around Berry Genomics Co.,Ltd's (SZSE:000710) Revenues As Shares Take 25% Pounding
PacBio Announces Shipment of Vega Systems to Berry Genomics